Reduced regional cerebral blood flow in Huntington's disease studied by SPECT.
Tóm tắt
Từ khóa
Tài liệu tham khảo
Conneally PM. Huntington's disease: Genetics and epidemiology. Am J Hum Genet 1984;36:506-26.
Vonsattel J-P, Myers RH, Stevens TJ, et al. Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985;44:559-77.
Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 1983;306:234-8.
Starkstein SE, Folstein SE, Brandt J, et al. Brain atrophy in Huntington's disease. A CT-scan study. Neuroradiology 1989;31: 156-9.
StoberT, WussowW, Schrimgrigk K. Bicaudate diameterthe most specific and simple CT parameter in the diagnosis of Huntington's disease. Neuroradiology 1984;26:25-8.
Bamford A, Caine ED, Kido DK, et al. Clinical-pathological correlation in Huntington's disease: A neuropsychological and computed tomography study. Neurology 1989;39:796-801.
Kuhl DE, Phelps ME, Markham CH, et al. Cerebral metabolism and atrophy in Huntington's disease by 18-FDG and computed tomographic scan. Ann Neurol 1982;12:425-34.
Hayden MR, Martin WR, W, Stoessl AJ, et al. Positron emission tomography in the early diagnosis of Huntington's disease. Neurology 1986;36:888-94.
Young AB, Penney JB, Starosta-Rubinstein S, et al. PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20:296-303.
Berent S, Giordani B, Lethinen S, et al. Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function. Ann Neurol 1988;23:541-6.
Simmons JT, Pastakia B, Chase TN, et al. Magnetic resonance imaging in Huntington's disease. AJNR 1986;7:25-8.
Weinberger DR, Berman KF, ladarola M, et al. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry 1988;51: 94-104.
Tanahashi N, Meyer JS, Ishikawa Y, et al. Cerebral blood flow and cognitive testing correlate in Huntington's disease. Arch Neurol 1985;42:1 169-75.
Waldemar G, Hasselbalch SG, Andersen AR, et al. [99"Tc]HMPAO and SPECT of the brain in normal aging. J Cereb Blood Flow Metabol 1991;11:508-21.
Shoulson I. Huntington's disease: Functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981;31:1333-5.
Stokely EM, Sveinsdottir E, Lassen NA, Rommer P. Single photon dynamic computer assisted tomograph (DCAT) for imaging brain function in multiple sections. J Comput Assist Tomogr 1980;4:230-40.
Celsis P, Goldman T, Henriksen L, Lassen NA. A method for calculating regional cerebral blood flow from emission computed tomography of inert gas concentrations. J Comput Assist Tomogr 1981;5:641-5.
Gade A, Mortensen EL, Udesen M, et al. On the importance of control data and background variables in the evaluation of neuropsychological aspects of brain functioning. In: Neurobehavioural methods in occupational and environmental health. Environmental Health Series. Copenhagen: WHO, 1985:91-6.
Gade A, Mortensen L, Bruhn P. "Chronic painter's syndrome". A reanalysis of psychological test data in a group of diagnosed cases, based on comparisons with matched controls. Acta Neurol Scand 1988;77:293-306.
Jeste DV, Barban L, Parisi J. Reduced Purkinje cell density in Huntington's Disease. Exp Neurol 1984;85:78-86.
Bedal MF, Swartz KJ, Finn SF, et al. Amino acid and neuropeptide neurotransmitters in Huntington's disease cerebellum. Brain Res 1989;454:393-6.
Lassen NA, Andersen AR, Friberg L, Paulson OB. The retention of Tc99m-D, L-HMPAO in the human brain after intracarotid bolus injection: a kinetic analysis. J Cereb Blood Flow Metab 1988;8(suppl 1):SSI3-22.
Kuwert T, Lange HW, Langen J, Herzog H, Aulich A Feinendegen LE. Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 1990;113(Pt 5):1405-23.